Debra Ehrlich

Trial of magnetic resonance–guided putaminal gene therapy for advanced Parkinson's disease

John D. Heiss, Codrin Lungu, Dima A. Hammoud et al. · Movement Disorders · 2019 · 117 citations · Full text

Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease

Sara Bandrés‐Ciga, Sara Sáez-Atiénzar, Jeff Kim et al. · Acta Neuropathologica · 2020 · 112 citations · Full text

Engineering, Genetics, Polygenic Risk +19

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in <scp><i>GBA</i></scp> Mutation Carriers

Gian Pal, Graziella Mangone, Emily J. Hill et al. · Annals of Neurology · 2022 · 94 citations · Full text

Heterozygous <i>PRKN</i> mutations are common but do not increase the risk of Parkinson’s disease

William Zhu, Xiaoping Huang, Esther Yoon et al. · Brain · 2021 · 66 citations · Full text

Long-term safety of MRI-guided administration of AAV2-GDNF and gadoteridol in the putamen of individuals with Parkinson’s disease

Matthew T. Rocco, Asad S. Akhter, Debra Ehrlich et al. · Molecular Therapy · 2022 · 52 citations · Full text